Allison Vagner focuses her practice on domestic and foreign patent prosecution, portfolio strategy and management, patentability and freedom-to-operate analyses and IP due diligence, serving clients across industry, academia and research institutions. Her practice draws on more than 20 years of experience with intellectual property, combined with 7 years of real-world laboratory work, to provide a deep scientific foundation to develop practical, commercial-minded strategies for protecting and leveraging her clients' innovations.
Allison brings particular depth in chemistry, biochemistry and the life sciences, collaborating with scientists, technology managers and executives alike to build focused, cost-effective patent portfolios aligned with her clients' commercial objectives. Her technical focus includes: small and mid-size molecule chemistry, including compounds and compositions for the pharmaceutical, agricultural, cosmetics, food science and semiconductor industries, molecular cell biology and cellular technologies, molecular diagnostics, medical devices and materials science.
Before pursuing graduate studies, Allison worked as a research and synthetic chemist at a high-tech optical networking startup, an experience that instilled a practical understanding of early-stage technology development and patent protection that continues to inform her approach to client work.
Representative experience
- IP due diligence - Represented foreign venture capital firm in US$100 million acquisition of technology holding company with a diverse international patent portfolio, with complex litigation history, extensive licensing issues and various ownership complications
- Pharmaceutical patent portfolio development - Represented early-stage pharmaceutical company in developing short-term and long-term patent filing strategies, including strategic international filings, defensive patent filings and investment filings, including managing the portfolio through corporate restructuring and clinical trials
- University technology commercialization - Represented research institution in establishing an international and comprehensive patent portfolio surrounding technology developed in collaboration with multiple parties (spin out company, partner research institutions and government research agencies), addressing licensing issues and strategically developing the portfolio through multiple funding rounds to maximize value
- Small and mid-size molecule chemistry - Pharmaceutical compound classes including activators, inhibitors, mimetics and derivatives, chemical synthesis and structure-property relationships, structure and/or computational-based drug design; crystallography and crystal structure analysis, drug combinations and pharmaceutical dosage forms, including tablet and capsule formulations.
- Molecular cell biology and cellular technologies - Cell-based platforms, including iPSCs, HPSCs, MSCs, organoid technologies and protein- and peptide-based therapeutics, encompassing methods of generation, structural and expression characterization, cellular constructs and compositions and therapeutic and research applications.
- Diagnostics and biomarker-driven medicine - Biomarker discovery, diagnostics and therapeutic targeting utilizing DNA-, RNA- and protein-based markers to stratify patient populations, define disease state and inform the selection and validation of therapeutic targets and candidates.
- AI/ML-enabled healthcare applications - Patient population identification and therapeutic response prediction, across pharmaceutical, medical device and digital health sectors.
- Nucleic acid and delivery technologies - LNP systems and DNA- and RNA-based modalities such as cDNA, siRNA, mRNA, miRNA and aptamers.
- Biomolecular and structural biology technologies - DNA‑, RNA‑, peptide‑ and protein‑based modalities and their structures, synthesis and therapeutic applications, residue and receptor binding interactions, antigen and neoantigen discovery and identification and hormone structure analysis, modification and use.
Education
- MA, Chemistry, University of Southern California Los Angeles, 2004
- BS, Chemistry, University of Washington, 2000
Admissions
- US Patent and Trademark Agent